by synergycap1 | Jun 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
British households are cutting back as the Brexit effect on the pound continues to raise living costs, according to a clutch of reports that show shops, car dealerships and other consumer-facing businesses coming under pressure last month. Uncertainty about the...
by synergycap1 | Jun 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Average UK rents have fallen for the first time in more than seven years, with London seeing the biggest decline, according to new data. The slowdown in the rental sector mirrors a similar picture in the housing market, with figures showing that property prices have...
by synergycap1 | Jun 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(App users please click here).
by synergycap1 | Jun 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Lead, Working Capital
Harvard University. It’s among the world’s most prestigious colleges, a field of academic dreams, and perhaps the hardest school in the world to get into. Now, for 10 students who were admitted but had their acceptances rescinded recently, it’s also...
by synergycap1 | Jun 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Non-Bank Loans, Working Capital
KELOWNA, B.C. – Carriers take huge risks transporting valuable goods from a shipper to a receiver, and according to Michael Silva, a lawyer with Whitelaw Twining Law, bills of lading may not be enough. If a common carrier, whose liability amounts to the...
by synergycap1 | Jun 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
A small company called Loxo Oncology thinks it can treat every cancer patient that harbors a specific, unusual, genetic mutation. The problem: finding them. The company’s drug, which could be on the market as early as next year, treats cancers with a...